Executive record

Rupert Vessey

Director at Bio-Techne

Follow
More
Challenge a Claim

Alpha ID: alpha:person:rupert-vesseyVersion: public-0As of: 2026-09-28

Not yet claimed11 published Claims4 sources
  • Director

Key Claims

Biography

Executive Partner and Chief Scientist at Flagship Pioneering. Former President of Research and Early Development at Bristol-Myers Squibb with deep expertise in medical and life science R&D.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: Executive Partner and Chief Scientist · Organization not publishedTECH DEF 14A director slate

Claims

Conflicts and accountability

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. TECH DEF 14A director slate

    sec filing · Source published: Sep 19, 2025 · Retrieved: Apr 29, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: Apr 29, 2026
    • Board role: Board role: Director · Claim reviewed: Apr 29, 2026
    • Committee assignments: Committee assignments: Science/Innovation, Compensation · Claim reviewed: Apr 29, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: Apr 29, 2026
    • Executive company: Executive at Flagship Pioneering, Inc. · Claim reviewed: Apr 29, 2026
    • Executive title: Executive title: Executive Partner and Chief Scientist · Claim reviewed: Apr 29, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: Apr 29, 2026

  2. Bio-Techne Corporation director board source

    sec filing · Source published: Sep 19, 2025 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Bio-Techne Corporation · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  3. Open source

    sec proxy · Source published: Sep 19, 2025 · Retrieved: Apr 29, 2026

    Supports 1 claim
    • Professional Role: Director at Bio-Techne · Claim reviewed: Sep 14, 2026

  4. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Bio-Techne Corporation · Claim reviewed: May 3, 2026